Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens.

Por A'Hern, R. P., Smith, I. E., Ebbs, S. R.
Publicado em 1993

Childhood T-cell lymphoblastic lymphoma--does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG).

Por Shepherd, S. F., A'Hern, R. P., Pinkerton, C. R.
Publicado em 1995

Does chemotherapy improve survival in advanced breast cancer? A statistical overview.

Por A'Hern, R. P., Ebbs, S. R., Baum, M. B.
Publicado em 1988

Leukopenia predicts outcome in haemato-oncological patients requiring intensive care

Por Margarson, MP, Gordon, AC, A'Hern, R, Skewes, D
Publicado em 2001

Was Young's syndrome caused by exposure to mercury in childhood?

Por Hendry, W F, A'Hern, R P, Cole, P J
Publicado em 1993

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).

Por Ling, P. J., A'Hern, R. P., Hardy, J. R.
Publicado em 1995

Fatigue in advanced cancer: a prospective controlled cross-sectional study

Por Stone, P, Hardy, J, Broadley, K, Kurowska, A, A'Hern, R
Publicado em 1999

Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer.

Por Haybittle, J. L., Brinkley, D., Houghton, J., A'Hern, R. P., Baum, M.
Publicado em 1989

Psychological effects of being offered choice of surgery for breast cancer.

Por Fallowfield, L. J., Hall, A., Maguire, P., Baum, M., A'Hern, R. P.
Publicado em 1994

Correlation of age and hormone replacement therapy with breast density as assessed by Quantra™

Por Skippage, PL, Wilkinson, LS, Allen, SD, Roche, N, Dowsett, M, A'Hern, R
Publicado no Breast Cancer Res (2009)

Surveillance following orchidectomy for stage I testicular seminoma.

Por Horwich, A., Alsanjari, N., A'Hern, R., Nicholls, J., Dearnaley, D. P., Fisher, C.
Publicado em 1992

The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer

Por Partridge, M, Emilion, G, Pateromichelakis, S, A'Hern, R, Lee, G, Phillips, E, Langdon, J
Publicado em 1999

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours

Por Jefferies, S, Edwards, S M, Hamoudi, R A, A'Hern, R, Foulkes, W, Goldgar, D, Eeles, R
Publicado em 2001

Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma

Por Waters, J S, Moss, C, Pyle, L, James, M, Hackett, S, A'Hern, R, Gore, M, Eisen, T
Publicado em 2004

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.

Por Johnston, S. R., Riddler, S., Haynes, B. P., A'Hern, R., Smith, I. E., Jarman, M., Dowsett, M.
Publicado em 1997

Breast cancer, prostaglandins and patient survival.

Por Bennett, A., Stamford, I. F., Berstock, D. A., Dische, F., Singh, L., A'Hern, R. P.
Publicado em 1989

Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?

Por Shah, S, Hardy, J, Rees, E, Ling, J, Gwilliam, B, Davis, C, Broadley, K, A'Hern, R
Publicado em 2002

Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone.

Por Price, P., Sinnett, H. D., Gusterson, B., Walsh, G., A'Hern, R. P., McKinna, J. A.
Publicado em 1990

Platinum-Taxol non-cross resistance in epithelial ovarian cancer.

Por Gore, M. E., Preston, N., A'Hern, R. P., Hill, C., Mitchell, P., Chang, J., Nicolson, M.
Publicado em 1995

Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer

Por Barton, S, Zabaglo, L, A'Hern, R, Turner, N, Ferguson, T, O'Neill, S, Hills, M, Smith, I, Dowsett, M
Publicado em 2012